Literature DB >> 34458930

Comparison of laparoscopic gastrectomy with 3-D/HD and 2-D/4 K camera system for gastric cancer: a prospective randomized control study.

Shingo Kanaji1, Yuta Yamazaki2, Takuya Kudo2, Hitoshi Harada2, Gosuke Takiguchi2, Naoki Urakawa2, Hiroshi Hasegawa2, Masashi Yamamoto2, Kimihiro Yamashita2, Takeru Matsuda2, Taro Oshikiri2, Tetsu Nakamura2, Satoshi Suzuki2, Yoshihiro Kakeji2.   

Abstract

PURPOSE: We conducted a prospective clinical control study to identify the best imaging technology among three-dimensional (3-D) high-definition (HD) stereovision and two-dimensional (2-D) ultra-high-resolution (4 K) technology and confirm their effects on surgical outcomes of laparoscopic gastrectomy for gastric cancer.
METHODS: From April 2018 to August 2019, 50 patients were randomly classified into two groups based on the imaging technology (3-D/HD group = 25, 2-D/4 K = 25). After excluding eight patients based on laparoscopic findings, 42 patients were analyzed (3-D/HD group = 21, 2-D/4 K = 21). The primary endpoint was the operative time; the secondary endpoints were blood loss, postoperative infectious complications, and postoperative hospital stay.
RESULTS: The patients' backgrounds were similar (sex, age, body mass index [BMI], stage, procedure, and extent of lymph node dissection). There were no significant differences in operative time (252 vs. 238 min, P = 0.70), total blood loss, postoperative infectious complications, and postoperative hospital stay between the two groups. However, video analysis of surgeries revealed a significantly shortened median operative time (18 vs. 25 min, P = 0.04) in the suturing step with 3-D/HD; the median number of camera cleaning procedures during suprapancreatic lymph node dissection was significantly lower with 2-D/4 K than with 3-D/HD (n = 4.4 vs. 2.8, P = 0.02).
CONCLUSION: 3-D/HD and 2-D/4 K laparoscopic radical gastrectomies provide similar surgical outcomes. However, the 3-D monitor reduces suturing time during reconstruction, while the 4 K monitor reduces the number of camera cleaning procedures during lymphadenectomy. TRIAL REGISTRATION: Registered in the University Hospital Medical Information Network Clinical Trials Registry (identification number 000029227).
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  2-D/4 K laparoscopy; 3-D/HD laparoscopy; Gastric cancer; Laparoscopic gastrectomy

Mesh:

Year:  2021        PMID: 34458930     DOI: 10.1007/s00423-021-02302-w

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  16 in total

1.  Delta-shaped anastomosis in totally laparoscopic Billroth I gastrectomy: new technique of intraabdominal gastroduodenostomy.

Authors:  Seiichiro Kanaya; Takashi Gomi; Hirohito Momoi; Nobuyuki Tamaki; Hisashi Isobe; Tetsuo Katayama; Yasuo Wada; Masahiro Ohtoshi
Journal:  J Am Coll Surg       Date:  2002-08       Impact factor: 6.113

Review 2.  The Conflicting Evidence of Three-dimensional Displays in Laparoscopy: A Review of Systems Old and New.

Authors:  Shinichiro Sakata; Marcus O Watson; Philip M Grove; Andrew R L Stevenson
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

3.  Comparison of two- and three-dimensional display for performance of laparoscopic total gastrectomy for gastric cancer.

Authors:  Shingo Kanaji; Satoshi Suzuki; Hitoshi Harada; Masayasu Nishi; Masashi Yamamoto; Takeru Matsuda; Taro Oshikiri; Tetsu Nakamura; Yasuhiro Fujino; Masahiro Tominaga; Yoshihiro Kakeji
Journal:  Langenbecks Arch Surg       Date:  2017-03-17       Impact factor: 3.445

4.  The viewpoint-specific failure of modern 3D displays in laparoscopic surgery.

Authors:  Shinichiro Sakata; Philip M Grove; Andrew Hill; Marcus O Watson; Andrew R L Stevenson
Journal:  Langenbecks Arch Surg       Date:  2016-08-19       Impact factor: 3.445

5.  Three-dimensional imaging improved the laparoscopic performance of inexperienced operators: a prospective trial.

Authors:  Shingo Kanaji; Ryohei Watanabe; Pietro Mascagni; Fabian Trauzettel; Takeshi Urade; Fabio Longo; Ludovica Guerriero; Silvana Perretta; Bernard Dallemagne; Yoshihiro Kakeji; Jacques Marescaux
Journal:  Surg Endosc       Date:  2019-12-06       Impact factor: 4.584

6.  Surgical outcomes in the newly introduced phase of intracorporeal anastomosis following laparoscopic distal gastrectomy is safe and feasible compared with established procedures of extracorporeal anastomosis.

Authors:  Shingo Kanaji; Hitoshi Harada; Shunji Nakayama; Takashi Yasuda; Taro Oshikiri; Kentaro Kawasaki; Masashi Yamamoto; Tatsuya Imanishi; Tetsu Nakamura; Satoshi Suzuki; Kenichi Tanaka; Yasuhiro Fujino; Masahiro Tominaga; Yoshihiro Kakeji
Journal:  Surg Endosc       Date:  2014-04       Impact factor: 4.584

7.  The learning effect of using stereoscopic vision in the early phase of laparoscopic surgical training for novices.

Authors:  Hitoshi Harada; Shingo Kanaji; Masayasu Nishi; Yoshito Otake; Hiroshi Hasegawa; Masashi Yamamoto; Yoshiko Matsuda; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Yasuo Sumi; Tetsu Nakamura; Satoshi Suzuki; Yoshinobu Sato; Yoshihiro Kakeji
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

8.  Is 3D faster and safer than 4K laparoscopic cholecystectomy? A randomised-controlled trial.

Authors:  Matt Dunstan; Ralph Smith; Katie Schwab; Andrea Scala; Piers Gatenby; Martin Whyte; Tim Rockall; Iain Jourdan
Journal:  Surg Endosc       Date:  2019-07-18       Impact factor: 4.584

9.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer.

Authors:  Jungang Liu; Haitao Zhou; Haiquan Qin; Haiming Ru; Jiahao Huang; Siyuan Liang; Xianwei Mo; Weizhong Tang
Journal:  Onco Targets Ther       Date:  2018-01-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.